Search company, investor...

Tibotec, Virco

tibotec-virco.com

Stage

IPO

Total Raised

$72.14M

Investors Count

4

Portfolio Exits

1

Investments

1

Funding, Valuation & Revenue

3 Fundings

Tibotec, Virco's latest funding round was a Acquired for on April 18, 2002.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/18/2002

Acquired

Undisclosed Investors

0

FY undefined

1

6/15/2001

Growth Equity - II

$99M

0

FY undefined

10

9/10/1999

Growth Equity

$99M

0

FY undefined

10

Date

4/18/2002

6/15/2001

9/10/1999

Round

Acquired

Growth Equity - II

Growth Equity

Amount

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

Sources

1

10

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Tibotec, Virco Investors

4 Investors

Tibotec, Virco has 4 investors. TrustCapital Partners invested in Tibotec, Virco's Growth Equity - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

9/10/1999

6/15/2001

2
Growth Equity, Growth Equity - II (2001)

Pascale Weber

00/00/0000

00/00/0000

Sofinim

Subscribe to see more

Subscribe to see more

Private Equity

Belgium

00/00/0000

00/00/0000

VIV NV

Subscribe to see more

Venture Capital

Belgium

00/00/0000

00/00/0000

Ibel

Subscribe to see more

Private Equity

Belgium

First funding

9/10/1999

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/15/2001

00/00/0000

00/00/0000

00/00/0000

Investor

Sofinim

VIV NV

Ibel

Rounds

2
Growth Equity, Growth Equity - II (2001)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Pascale Weber

Subscribe to see more

Type

Private Equity

Venture Capital

Private Equity

Location

Belgium

Belgium

Belgium

Tibotec, Virco Acquisitions

1 Acquisition

Tibotec, Virco acquired 1 company. Their latest acquisition was Virco on April 16, 2001.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/16/2001

Series A

$99M

Merger

1

Date

4/16/2001

Investment Stage

Series A

Companies

Valuation

$99M

Total Funding

Note

Merger

Sources

1

Tibotec, Virco Investments

1 Investments

Tibotec, Virco has made 1 investments. Their latest investment was in Galapagos Genomics as part of their Corporate Minority on June 6, 1999.

CBI Logo

Tibotec, Virco Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/1/1999

Corporate Minority

Galapagos Genomics

$7.26M

Yes

Crucell, Tibotec, Virco, and Undisclosed Investors

1

Date

6/1/1999

Round

Corporate Minority

Company

Galapagos Genomics

Amount

$7.26M

New?

Yes

Co-Investors

Crucell, Tibotec, Virco, and Undisclosed Investors

Sources

1

Tibotec, Virco Portfolio Exits

1 Portfolio Exit

Tibotec, Virco has 1 portfolio exit. Their latest portfolio exit was Galapagos Genomics on May 06, 2005.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/6/2005

IPO

$99M

Public

Date

5/6/2005

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.